vs

Side-by-side financial comparison of ALERUS FINANCIAL CORP (ALRS) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $45.2M, roughly 1.8× ALERUS FINANCIAL CORP). PROCEPT BioRobotics Corp runs the higher net margin — -38.1% vs -73.2%, a 35.1% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 18.0%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -2.5%).

Alerus Financial Corporation, marketed as simply Alerus, is a chain of financial institutions headquartered in Grand Forks, North Dakota, with locations in North Dakota, Minnesota, Wisconsin, and Arizona. Alerus offers banking, mortgage, wealth management, and retirement services.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

ALRS vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.8× larger
PRCT
$83.1M
$45.2M
ALRS
Growing faster (revenue YoY)
PRCT
PRCT
+2.2% gap
PRCT
20.2%
18.0%
ALRS
Higher net margin
PRCT
PRCT
35.1% more per $
PRCT
-38.1%
-73.2%
ALRS
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-2.5%
ALRS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ALRS
ALRS
PRCT
PRCT
Revenue
$45.2M
$83.1M
Net Profit
$-33.1M
$-31.6M
Gross Margin
64.9%
Operating Margin
-96.0%
-4.1%
Net Margin
-73.2%
-38.1%
Revenue YoY
18.0%
20.2%
Net Profit YoY
-49232.8%
-27.9%
EPS (diluted)
$-1.27
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALRS
ALRS
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$45.2M
$76.4M
Q3 25
$72.6M
$83.3M
Q2 25
$74.8M
$79.2M
Q1 25
$68.8M
$69.2M
Q4 24
$72.2M
$68.2M
Q3 24
$50.9M
$58.4M
Q2 24
$51.4M
$53.4M
Net Profit
ALRS
ALRS
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-33.1M
$-29.8M
Q3 25
$16.9M
$-21.4M
Q2 25
$20.3M
$-19.6M
Q1 25
$13.3M
$-24.7M
Q4 24
$-67.0K
$-18.9M
Q3 24
$5.2M
$-21.0M
Q2 24
$6.2M
$-25.6M
Gross Margin
ALRS
ALRS
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
ALRS
ALRS
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-96.0%
-40.6%
Q3 25
30.4%
-27.8%
Q2 25
35.2%
-28.0%
Q1 25
25.5%
-39.7%
Q4 24
-0.8%
-28.9%
Q3 24
13.4%
-38.4%
Q2 24
15.8%
-50.3%
Net Margin
ALRS
ALRS
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-73.2%
-39.1%
Q3 25
23.3%
-25.7%
Q2 25
27.1%
-24.7%
Q1 25
19.4%
-35.8%
Q4 24
-0.2%
-27.6%
Q3 24
10.2%
-35.9%
Q2 24
12.1%
-48.0%
EPS (diluted)
ALRS
ALRS
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-1.27
$-0.54
Q3 25
$0.65
$-0.38
Q2 25
$0.78
$-0.35
Q1 25
$0.52
$-0.45
Q4 24
$-0.06
$-0.34
Q3 24
$0.26
$-0.40
Q2 24
$0.31
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALRS
ALRS
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$67.2M
$245.6M
Total DebtLower is stronger
$59.2M
$51.7M
Stockholders' EquityBook value
$564.9M
$347.7M
Total Assets
$5.2B
$487.1M
Debt / EquityLower = less leverage
0.10×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALRS
ALRS
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$67.2M
$286.5M
Q3 25
$92.0M
$294.3M
Q2 25
$80.9M
$302.7M
Q1 25
$83.0M
$316.2M
Q4 24
$61.2M
$333.7M
Q3 24
$66.0M
$196.8M
Q2 24
$438.1M
$214.1M
Total Debt
ALRS
ALRS
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$59.2M
$51.6M
Q3 25
$59.2M
$51.6M
Q2 25
$59.1M
$51.5M
Q1 25
$59.1M
$51.5M
Q4 24
$59.1M
$51.5M
Q3 24
$59.0M
$51.4M
Q2 24
$59.0M
$51.4M
Stockholders' Equity
ALRS
ALRS
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$564.9M
$365.9M
Q3 25
$550.7M
$380.3M
Q2 25
$533.2M
$385.8M
Q1 25
$514.2M
$389.2M
Q4 24
$495.4M
$402.2M
Q3 24
$386.5M
$241.2M
Q2 24
$373.2M
$251.8M
Total Assets
ALRS
ALRS
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$5.2B
$508.1M
Q3 25
$5.3B
$511.5M
Q2 25
$5.3B
$513.1M
Q1 25
$5.3B
$519.4M
Q4 24
$5.3B
$534.0M
Q3 24
$4.4B
$374.1M
Q2 24
$4.4B
$374.4M
Debt / Equity
ALRS
ALRS
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.10×
0.14×
Q3 25
0.11×
0.14×
Q2 25
0.11×
0.13×
Q1 25
0.11×
0.13×
Q4 24
0.12×
0.13×
Q3 24
0.15×
0.21×
Q2 24
0.16×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALRS
ALRS
PRCT
PRCT
Operating Cash FlowLast quarter
$67.5M
Free Cash FlowOCF − Capex
$58.8M
FCF MarginFCF / Revenue
130.2%
Capex IntensityCapex / Revenue
19.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$102.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALRS
ALRS
PRCT
PRCT
Q1 26
Q4 25
$67.5M
$-10.3M
Q3 25
$32.8M
$-6.6M
Q2 25
$10.7M
$-15.0M
Q1 25
$7.7M
$-17.0M
Q4 24
$21.7M
$-32.4M
Q3 24
$20.2M
$-18.8M
Q2 24
$-12.5M
$-15.7M
Free Cash Flow
ALRS
ALRS
PRCT
PRCT
Q1 26
Q4 25
$58.8M
$-12.2M
Q3 25
$30.3M
$-9.5M
Q2 25
$7.6M
$-17.8M
Q1 25
$5.7M
$-18.8M
Q4 24
$9.4M
$-33.6M
Q3 24
$17.4M
$-19.0M
Q2 24
$-16.1M
$-16.8M
FCF Margin
ALRS
ALRS
PRCT
PRCT
Q1 26
Q4 25
130.2%
-15.9%
Q3 25
41.8%
-11.4%
Q2 25
10.1%
-22.5%
Q1 25
8.2%
-27.2%
Q4 24
13.0%
-49.2%
Q3 24
34.2%
-32.6%
Q2 24
-31.4%
-31.4%
Capex Intensity
ALRS
ALRS
PRCT
PRCT
Q1 26
Q4 25
19.3%
2.4%
Q3 25
3.4%
3.4%
Q2 25
4.2%
3.5%
Q1 25
3.0%
2.7%
Q4 24
17.1%
1.7%
Q3 24
5.4%
0.4%
Q2 24
7.2%
2.0%
Cash Conversion
ALRS
ALRS
PRCT
PRCT
Q1 26
Q4 25
Q3 25
1.94×
Q2 25
0.53×
Q1 25
0.58×
Q4 24
Q3 24
3.88×
Q2 24
-2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALRS
ALRS

Other$17.3M38%
Retirement And Benefit Services$17.3M38%
Wealth Management$7.4M16%
Mortgage Banking$3.2M7%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons